CLINICAL_TRIALS
trial_result
· 2025-11-28
Clinical Trial Update: Percutaneous Deep Vein Arterialization Post-Market Study [NA]
Summary
A completed post-market study evaluating Percutaneous Deep Vein Arterialization for Critical Limb Ischemia has posted results. The sponsor is LimFlow SA.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: LimFlow SA | Conditions: Critical Limb Ischemia | NA | Status: COMPLETED | Results posted: 2025-11-28